62 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
RDY Dr. Reddy's Laboratories Ltd $35.7 $5.93B N/A
Article Searches
New Strong Sell Stocks for April 11th http://www.zacks.com/stock/news/256038/new-strong-sell-stocks-for-april-11th?cid=CS-ZC--256038 Apr 11, 2017 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
BioMarin (BMRN) Posts Earnings in Q1, Sales Top, Stock Up http://www.zacks.com/stock/news/259583/biomarin-bmrn-posts-earnings-in-q1-sales-top-stock-up?cid=CS-ZC-FT-259583 May 05, 2017 - BioMarin Pharmaceutical Inc. (BMRN) reported earnings of 3 cents per share in the first quarter of 2017.
Dr. Reddy's Laboratories' (RDY) Q4 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4073410-dr-reddys-laboratories-rdy-q4-2017-results-earnings-call-transcript?source=feed_tag_india May 15, 2017 - Dr.Reddy's Laboratories Limited (ADR) (NYSE:RDY) Q4 2017 Earnings Conference Call May 12, 2017 08:30 AM ET Executives Saunak Savla - Head of Investor Relations Saumen Chakraborty - Chief Financial Off
Dr. Reddy's Laboratories Limited (RDY) Presents At Jefferies 2017 Global Healthcare Conference - Slideshow https://seekingalpha.com/article/4079633-dr-reddys-laboratories-limited-rdy-presents-jefferies-2017-global-healthcare-conference?source=feed_tag_india Jun 07, 2017 - The following slide deck was published by Dr. Reddy's Laboratories Limited in conjunction with this event.
Dr. Reddy's Laboratories' (RDY) Q2 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4118545-dr-reddys-laboratories-rdy-q2-2018-results-earnings-call-transcript?source=feed_sector_healthcare Oct 31, 2017 - Dr. Reddy's Laboratories Limited (NYSE:RDY) Q2 2018 Earnings Conference Call October 31, 2017, 09:00 AM ET Executives Saunak Savla - Head of IR Saumen Chakraborty - CFO Abhijit Mukherjee - COO Anil Na
Even in This Rich Market, Celgene Is Offering Investors Value https://www.fool.com/investing/2018/05/10/even-in-this-rich-market-celgene-is-offering-inves.aspx?source=iedfolrf0000001 May 10, 2018 - This beaten-down biotech stock should still be a solid winner for patient investors.
Dr. Reddy's Laboratories Limited (RDY) CEO G.V. Prasad on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4176612-dr-reddys-laboratories-limited-rdy-ceo-g-v-prasad-q4-2018-results-earnings-call-transcript?source=feed_tag_india May 23, 2018 - Dr. Reddy's Laboratories Limited (NYSE:RDY) Q4 2018 Earnings Conference Call May 22, 2018 09:00 AM ET Executives Saunak Savla - Investor Relations G.V. Prasad - Chief Executive Officer Erez Israeli -
Celgene's CEO Wants to Make the Biotech's Best-Selling Drug Obsolete -- Here's Why That's Great for Investors https://www.fool.com/investing/2018/09/07/celgenes-ceo-wants-to-make-the-biotechs-best-selli.aspx?source=iedfolrf0000001 Sep 07, 2018 - Revlimid is Celgene's biggest moneymaker by far. But here's how and why CEO Mark Alles wants to make it disappear.
J&J (JNJ) Gets FDA Nod for New Prostate Cancer Treatment (Revised) http://www.zacks.com/stock/news/292663/jj-jnj-gets-fda-nod-for-new-prostate-cancer-treatment-revised?cid=CS-ZC-FT-292663 Feb 15, 2018 - J&J (JNJ) Gets FDA approval for Erleada (apalutamide) for the treatment of non-metastatic castration-resistant prostate cancer.
Pharma Stocks Weighed Down by Competition, Generic Pressure http://www.zacks.com/commentary/152552/pharma-stocks-weighed-down-by-competition-generic-pressure?cid=CS-ZC--152552 Mar 09, 2018 - Pharma Stocks Weighed Down by Competition, Generic Pressure

Pages: 1234567

<<<Page 4>